Straumann Holding AG Revenue 2012-2025 | SAUHY
Straumann Holding AG annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Straumann Holding AG revenue for the quarter ending December 31, 2025 was $0M, a 0% increase year-over-year.
- Straumann Holding AG revenue for the twelve months ending December 31, 2025 was $0M, a 0% increase year-over-year.
- Straumann Holding AG annual revenue for 2025 was $3.145B, a 10.57% increase from 2024.
- Straumann Holding AG annual revenue for 2024 was $2.844B, a 5.87% increase from 2023.
- Straumann Holding AG annual revenue for 2023 was $2.687B, a 10.47% increase from 2022.
|
Straumann Holding AG Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $3,145 |
| 2024 | $2,844 |
| 2023 | $2,687 |
| 2022 | $2,432 |
| 2021 | $2,212 |
| 2020 | $1,521 |
| 2019 | $1,607 |
| 2018 | $1,394 |
| 2017 | $1,130 |
| 2016 | $932 |
| 2015 | $831 |
| 2014 | $777 |
| 2013 | $734 |
| 2012 | $732 |
| 2011 | $785 |
|
Straumann Holding AG Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-12-31 | |
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2018-12-31 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2014-12-31 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $16.902B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |